Skip to main content
Log in

The Hypolipidemic Activity of N-(p-Chlorobenzoyl)-sulfamate in Rodents and its Effect on Lipid Metabolism

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

N-(p-Chlorobenzoyl)-sulfamate was observed to produce potent hypolipidemic activity in rodents at 10 to 60 mg/kg/day. Liver phosphatidate phosphohydrolase and sn-glycerol-3-phosphate acyl transferase activities were suppressed by the agent in vitro and in vivo, and ATP dependent citrate lyase and acetyl CoA carboxylase activities were reduced in vivo. N-(p-Chlorobenzoyl)-sulfamate reduced cholesterol, neutral lipids, and triglycerides in the liver and increased excretion of cholesterol and neutral lipids in the bile and feces. Drug treatment reduced the neutral lipid and triglyceride content of serum chylomicrons, VLDL and LDL, and cholesterol content was reduced in the chylomicron and HDL fractions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wyrick, S. D., Hall, I. H., Dubey, A. S. (1983) J. Pharm. Sci. (in press).

  2. Hall, I. H., Voorstad, P. J., Chapman, J. M., Cocolas, G. H. (1983) J. Pharm. Sci. (in press).

  3. Ness, A. T., Pastewka, J. V., Peacock, A. C. (1964) Clin. Chim. Acta. 10, 229–237.

    Google Scholar 

  4. Litchfield, Jr., J. T., Wilcoxon, F. (1949) J. Pharmacol. Exp. Ther. 96, 99–113.

    Google Scholar 

  5. Goodridge, A. G. (1973) J. Biol. Chem. 248, 4318–4327.

    Google Scholar 

  6. Hoffman, M., Weiss, L., Wieland, O. H. (1978) Anal. Biochem. 84, 441–448.

    Google Scholar 

  7. Robinson, B. H., Williams, G. R., Halperin, M. L., Leznoff, C. C. (1970) Eur. J. Biochem. 15, 263–272.

    Google Scholar 

  8. Robinson, B. H., Williams, G. R. (1970) Biochim. Biophys. Acta. 216, 63–70.

    Google Scholar 

  9. Kritchevsky, D., Tepper, S. A. (1973) Atherosclerosis 18, 93–99.

    Google Scholar 

  10. Haven, G. T., Krzemien, J. R., Nguyen, T. T. (1973) Res. Commun. Chem. Pathol. Pharmacol. 6, 253–261.

    Google Scholar 

  11. Wada, F., Hirata, K., Sakameto, Y. (1969) J. Biochem. 65, 171–175.

    Google Scholar 

  12. Greenspan, M. D., Lowenstein, J. M. (1968) J. Biol. Chem. 243, 6273–6280.

    Google Scholar 

  13. Brady, R. O., Bradley, R. M., Trams, E. G. (1960) J. Biol. Chem. 235, 3093–3098.

    Google Scholar 

  14. Lamb, R. G., Wyrick, S. D., Piantadosi, C. (1977) Atherosclerosis 27, 147–154.

    Google Scholar 

  15. Mavis, R. D., Finkelstein, J. N., Hall, B. P. (1978) J. Lipid Res. 19, 467–477.

    Google Scholar 

  16. Folch, J., Lees, M., Stanley, G. H. C. (1957) J. Biol. Chem. 226, 497–509.

    Google Scholar 

  17. Bligh, E. G., Dyer, W. J. (1959) Can. J. Biochem. Physiol. 37, 911–917.

    Google Scholar 

  18. Bragdon, J. H. (1951) J. Biol. Chem. 190, 513–517.

    Google Scholar 

  19. Stewart, C. P., Henday, E. B. (1935) Biochem. J. 29, 1683–1689.

    Google Scholar 

  20. Adam, A., van Cantfort, J., Gielen, J. (1976) Lipids 11, 610–615.

    Google Scholar 

  21. Hatch, F. T., Lees, R. S. (1968) Adv. Lipid Res. 6, 1–68.

    Google Scholar 

  22. Havel, R. J., Eder, H. A., Bragdon, J. H. (1955) J. Clin. Invest. 34, 1345–1353.

    Google Scholar 

  23. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) J. Biol. Chem. 193, 265–275.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hall, I.H., Wyrick, S.D., Voorstad, P.J. et al. The Hypolipidemic Activity of N-(p-Chlorobenzoyl)-sulfamate in Rodents and its Effect on Lipid Metabolism. Pharm Res 1, 28–32 (1984). https://doi.org/10.1023/A:1016326625380

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016326625380

Keywords

Navigation